Press release Gothenburg, Sweden, September 23, 2022
Getinge appoints Joanna Engelke as new Executive Vice President Quality Compliance, Regulatory & Medical Affairs and member of the Getinge Executive Team
Joanna Engelke has been appointed new Executive Vice President Quality Compliance, Regulatory & Medical Affairs and member of the Getinge Executive Team. She takes up the position on October 6, 2022.
Joanna Engelke most recently held the position as Head of New Ventures and Chief Quality Officer for JUUL Labs. Prior to JUUL Labs, she held leading positions as Senior Vice President Global Quality & Regulatory Affairs at Boston Scientific Corporation, Managing Director at Holloran Consulting Group and Portfolio CEO, Biospecific at PureTech Ventures among others. Joanna brings broad and solid experience from areas of regulatory healthcare in international companies.
Joanna will be a member of the Getinge Executive Team and report to Mattias Perjos, President & CEO. She takes up the position on October 6, 2022 replacing Lena Hagman, current EVP Quality Compliance, Regulatory & Medical Affairs who, as earlier communicated, has decided to leave the company.
To secure a smooth transition of handing over the overall quality responsibilities and plans, Lena Hagman will continue to support Getinge to the extent needed for a period of time.
Media contact:
Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
E-mail: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.